The aseptic processing market is thriving due to the demand for sterile, self-stable products in food, beverage, and ...

Amid the pharma industry's breakneck onshoring push this past year, North Carolina has been a major beneficiary as investment announcements rolled in from the likes of ...

Compounding chemotherapy refers to the process of preparing personalized chemotherapy treatments by combining or altering the ...

The CNPV program aims to reduce drug review times to 1-2 months, raising concerns about safety and regulatory scrutiny. Critics argue that accelerated timelines may lead to safety issues and strain ...

The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...

That’s exactly what happens at Battery Street Jeans Exchange in Burlington, Vermont—a secondhand wonderland where vintage enthusiasts find their happy place and wallets remain surprisingly intact.

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.

Manufacturing is getting a major system upgrade. As AI amplifies existing technologies—like digital twins, the cloud, edge ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

The new Propelus Prototype Centers in Oregon and Minnesota will help customers accelerate the pace of life-saving innovation.

Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...